{"id":391649,"date":"2020-12-02T08:04:09","date_gmt":"2020-12-02T13:04:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=391649"},"modified":"2020-12-02T08:04:09","modified_gmt":"2020-12-02T13:04:09","slug":"gamida-cell-to-host-virtual-pipeline-deep-dive","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/","title":{"rendered":"Gamida Cell to Host Virtual Pipeline Deep Dive"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Gamida Cell to Host Virtual Pipeline Deep Dive<\/b><\/p>\n<p class=\"bwalignc\">\n\u00a0<i>&#8211; Focused on omidubicel,<\/i><i>an advanced cell therapy, including a review of Phase 3 clinical data, and GDA-201, a natural killer cell therapy \u2013<\/i><\/p>\n<p class=\"bwalignc\"><i>&#8211; Event to feature an omidubicel patient\u2019s perspective &#8211;<\/i><\/p>\n<p class=\"bwalignc\"><i>&#8211; Live webcast on December 9, 2020 at 8:00 a.m. ET &#8211;<\/i><\/p>\n<p>BOSTON&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced today that it will host a virtual event discussing the company\u2019s pipeline, including omidubicel, an advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of a bone marrow transplant, and GDA-201, an investigational, natural killer (NK) cell-based cancer immunotherapy, on Wednesday, December 9, 2020 at 8:00 a.m. ET.\n<\/p>\n<p>\nThe live event will be available at the following <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fonlinexperiences.com%2FLaunch%2FQReg%2FShowUUID%3D97B98D4E-E3FE-4EA7-9EB7-D478CB0116BD%26LangLocaleID%3D1033&amp;esheet=52341010&amp;newsitemid=20201202005565&amp;lan=en-US&amp;anchor=link&amp;index=1&amp;md5=fff667f672b2eb943e45126aa6667f2e\">link<\/a>.<i \/>A replay of the webcast will be available in the \u201cInvestors &amp; Media\u201d section of the Gamida Cell website, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gamida-cell.com&amp;esheet=52341010&amp;newsitemid=20201202005565&amp;lan=en-US&amp;anchor=www.gamida-cell.com&amp;index=2&amp;md5=63c2f5f59b423c64ca562374d942cb6f\">www.gamida-cell.com<\/a>, and will be available for at least 14 days following the event.\n<\/p>\n<p><b>About Gamida Cell<\/b><\/p>\n<p>\nGamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gamida-cell.com%2F&amp;esheet=52341010&amp;newsitemid=20201202005565&amp;lan=en-US&amp;anchor=www.gamida-cell.com&amp;index=3&amp;md5=800b65b8840cf0115ee117ed2238847f\">www.gamida-cell.com<\/a> or follow Gamida Cell on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fgamida-cell-ltd-%2F&amp;esheet=52341010&amp;newsitemid=20201202005565&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=e4f3b97992f4c3b40fbd5a6b397b02c8\">LinkedIn<\/a> or Twitter at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FGamidaCellTx&amp;esheet=52341010&amp;newsitemid=20201202005565&amp;lan=en-US&amp;anchor=%40GamidaCellTx&amp;index=5&amp;md5=d0faa55ddb26115ddbbc20b843e1c6a9\">@GamidaCellTx<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201202005565\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201202005565\/en\/<\/a><\/span><\/p>\n<p><i>For investors:<br \/>\n<\/i><br \/>Stephanie Ascher<br \/>\n<br \/>Stern Investor Relations, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:stephanie.ascher@sternir.com\">stephanie.ascher@sternir.com<br \/>\n<\/a><br \/>1-212-362-1200\n<\/p>\n<p><i>For media:<br \/>\n<\/i><br \/>Matthew Corcoran<br \/>\n<br \/>Ten Bridge Communications<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:mcorcoran@tenbridgecommunications.com\">mcorcoran@tenbridgecommunications.com<br \/>\n<\/a><br \/>1-617-866-7350\n<\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Gamida Cell to Host Virtual Pipeline Deep Dive \u00a0&#8211; Focused on omidubicel,an advanced cell therapy, including a review of Phase 3 clinical data, and GDA-201, a natural killer cell therapy \u2013 &#8211; Event to feature an omidubicel patient\u2019s perspective &#8211; &#8211; Live webcast on December 9, 2020 at 8:00 a.m. ET &#8211; BOSTON&#8211;(BUSINESS WIRE)&#8211; Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced today that it will host a virtual event discussing the company\u2019s pipeline, including omidubicel, an advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of a bone marrow transplant, and GDA-201, an investigational, natural killer (NK) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gamida Cell to Host Virtual Pipeline Deep Dive&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-391649","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Gamida Cell to Host Virtual Pipeline Deep Dive \u00a0&#8211; Focused on omidubicel,an advanced cell therapy, including a review of Phase 3 clinical data, and GDA-201, a natural killer cell therapy \u2013 &#8211; Event to feature an omidubicel patient\u2019s perspective &#8211; &#8211; Live webcast on December 9, 2020 at 8:00 a.m. ET &#8211; BOSTON&#8211;(BUSINESS WIRE)&#8211; Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced today that it will host a virtual event discussing the company\u2019s pipeline, including omidubicel, an advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of a bone marrow transplant, and GDA-201, an investigational, natural killer (NK) &hellip; Continue reading &quot;Gamida Cell to Host Virtual Pipeline Deep Dive&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T13:04:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gamida Cell to Host Virtual Pipeline Deep Dive\",\"datePublished\":\"2020-12-02T13:04:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/\"},\"wordCount\":299,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/\",\"name\":\"Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-02T13:04:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gamida-cell-to-host-virtual-pipeline-deep-dive\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gamida Cell to Host Virtual Pipeline Deep Dive\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/","og_locale":"en_US","og_type":"article","og_title":"Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk","og_description":"Gamida Cell to Host Virtual Pipeline Deep Dive \u00a0&#8211; Focused on omidubicel,an advanced cell therapy, including a review of Phase 3 clinical data, and GDA-201, a natural killer cell therapy \u2013 &#8211; Event to feature an omidubicel patient\u2019s perspective &#8211; &#8211; Live webcast on December 9, 2020 at 8:00 a.m. ET &#8211; BOSTON&#8211;(BUSINESS WIRE)&#8211; Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, announced today that it will host a virtual event discussing the company\u2019s pipeline, including omidubicel, an advanced cell therapy in Phase 3 clinical development as a potentially life-saving treatment option for patients in need of a bone marrow transplant, and GDA-201, an investigational, natural killer (NK) &hellip; Continue reading \"Gamida Cell to Host Virtual Pipeline Deep Dive\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T13:04:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gamida Cell to Host Virtual Pipeline Deep Dive","datePublished":"2020-12-02T13:04:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/"},"wordCount":299,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/","name":"Gamida Cell to Host Virtual Pipeline Deep Dive - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-02T13:04:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201202005565r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gamida-cell-to-host-virtual-pipeline-deep-dive\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gamida Cell to Host Virtual Pipeline Deep Dive"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=391649"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391649\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=391649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=391649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=391649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}